DK1667975T3 - En polymorf form for 3-phenylsulfonyl-8-piperazin-1-yl-quinolin - Google Patents
En polymorf form for 3-phenylsulfonyl-8-piperazin-1-yl-quinolinInfo
- Publication number
- DK1667975T3 DK1667975T3 DK04765655T DK04765655T DK1667975T3 DK 1667975 T3 DK1667975 T3 DK 1667975T3 DK 04765655 T DK04765655 T DK 04765655T DK 04765655 T DK04765655 T DK 04765655T DK 1667975 T3 DK1667975 T3 DK 1667975T3
- Authority
- DK
- Denmark
- Prior art keywords
- phenylsulfonyl
- piperazin
- quinoline
- polymorphic form
- polymorphic
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/38—Nitrogen atoms
- C07D215/40—Nitrogen atoms attached in position 8
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Child & Adolescent Psychology (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Hospice & Palliative Care (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Quinoline Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0322629.7A GB0322629D0 (en) | 2003-09-26 | 2003-09-26 | Novel compound |
| PCT/EP2004/010843 WO2005040124A1 (en) | 2003-09-26 | 2004-09-23 | A polymorphic form of 3-phenylsulfonyl -8-piperazin-1-yl-quinoline |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1667975T3 true DK1667975T3 (da) | 2008-04-14 |
Family
ID=29286934
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK04765655T DK1667975T3 (da) | 2003-09-26 | 2004-09-23 | En polymorf form for 3-phenylsulfonyl-8-piperazin-1-yl-quinolin |
Country Status (24)
| Country | Link |
|---|---|
| US (1) | US20070032504A1 (ja) |
| EP (1) | EP1667975B1 (ja) |
| JP (1) | JP2007506702A (ja) |
| CN (1) | CN1856471A (ja) |
| AU (1) | AU2004283805A1 (ja) |
| BR (1) | BRPI0414678A (ja) |
| CA (1) | CA2540022A1 (ja) |
| CO (1) | CO5680402A2 (ja) |
| DE (1) | DE602004010410T2 (ja) |
| DK (1) | DK1667975T3 (ja) |
| ES (1) | ES2297465T3 (ja) |
| GB (1) | GB0322629D0 (ja) |
| HK (1) | HK1094190A1 (ja) |
| HR (1) | HRP20080055T3 (ja) |
| IL (1) | IL174213A0 (ja) |
| IS (1) | IS8399A (ja) |
| MA (1) | MA28093A1 (ja) |
| MX (1) | MXPA06003375A (ja) |
| NO (1) | NO20061791L (ja) |
| PL (1) | PL1667975T3 (ja) |
| PT (1) | PT1667975E (ja) |
| RU (1) | RU2355681C2 (ja) |
| WO (1) | WO2005040124A1 (ja) |
| ZA (1) | ZA200601453B (ja) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2003080580A2 (en) * | 2002-03-27 | 2003-10-02 | Glaxo Group Limited | Quinoline derivatives and their use as 5-ht6 ligands |
| CN1826322B (zh) | 2003-07-22 | 2012-04-18 | 艾尼纳制药公司 | 用于预防和治疗相关病症而作为5-ht2a血清素受体调节剂的二芳基和芳基杂芳基脲衍生物 |
| NZ542865A (en) | 2003-09-18 | 2009-04-30 | Virobay Inc | Haloalkyl containing compounds as cysteine protease inhibitors |
| BRPI0611516A2 (pt) | 2005-06-02 | 2010-09-14 | Hoffmann La Roche | 3-metanossulfonilquinolinas como realçadores ("enhancers") de gaba-b |
| GB0519758D0 (en) * | 2005-09-28 | 2005-11-09 | Glaxo Group Ltd | Novel process |
| EP2120950B1 (en) * | 2007-03-21 | 2012-07-04 | Glaxo Group Limited | Use of quinoline derivatives in the treatment of pain |
| EP2508177A1 (en) | 2007-12-12 | 2012-10-10 | Glaxo Group Limited | Combinations comprising 3-phenylsulfonyl-8-piperazinyl-1yl-quinoline |
| US20110021538A1 (en) | 2008-04-02 | 2011-01-27 | Arena Pharmaceuticals, Inc. | Processes for the preparation of pyrazole derivatives useful as modulators of the 5-ht2a serotonin receptor |
| WO2010062321A1 (en) | 2008-10-28 | 2010-06-03 | Arena Pharmaceuticals, Inc. | Processes useful for the preparation of 1-[3-(4-bromo-2-methyl-2h-pyrazol-3-yl)-4-methoxy-phenyl]-3-(2,4-difluoro-phenyl)-urea and crystalline forms related thereto |
| AU2016276966A1 (en) | 2015-06-12 | 2018-01-18 | Axovant Sciences Gmbh | Diaryl and arylheteroaryl urea derivatives useful for the prophylaxis and treatment of REM sleep behavior disorder |
| TW201720439A (zh) | 2015-07-15 | 2017-06-16 | Axovant Sciences Gmbh | 用於預防及治療與神經退化性疾病相關的幻覺之作為５－ｈｔ２ａ血清素受體的二芳基及芳基雜芳基脲衍生物 |
| WO2017202206A1 (zh) * | 2016-05-27 | 2017-11-30 | 深圳市塔吉瑞生物医药有限公司 | 一种取代的喹啉化合物及其药物组合物 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9818916D0 (en) * | 1998-08-28 | 1998-10-21 | Smithkline Beecham Plc | Use |
| WO2003080580A2 (en) * | 2002-03-27 | 2003-10-02 | Glaxo Group Limited | Quinoline derivatives and their use as 5-ht6 ligands |
| GB0321473D0 (en) * | 2003-09-12 | 2003-10-15 | Glaxo Group Ltd | Novel compounds |
-
2003
- 2003-09-26 GB GBGB0322629.7A patent/GB0322629D0/en not_active Ceased
- 2003-09-26 PT PT04765655T patent/PT1667975E/pt unknown
-
2004
- 2004-09-23 BR BRPI0414678-6A patent/BRPI0414678A/pt not_active IP Right Cessation
- 2004-09-23 PL PL04765655T patent/PL1667975T3/pl unknown
- 2004-09-23 EP EP04765655A patent/EP1667975B1/en not_active Expired - Lifetime
- 2004-09-23 CA CA002540022A patent/CA2540022A1/en not_active Abandoned
- 2004-09-23 WO PCT/EP2004/010843 patent/WO2005040124A1/en active IP Right Grant
- 2004-09-23 CN CNA2004800275278A patent/CN1856471A/zh active Pending
- 2004-09-23 RU RU2006114024/04A patent/RU2355681C2/ru active
- 2004-09-23 JP JP2006527373A patent/JP2007506702A/ja not_active Withdrawn
- 2004-09-23 MX MXPA06003375A patent/MXPA06003375A/es active IP Right Grant
- 2004-09-23 US US10/572,670 patent/US20070032504A1/en not_active Abandoned
- 2004-09-23 AU AU2004283805A patent/AU2004283805A1/en not_active Abandoned
- 2004-09-23 ES ES04765655T patent/ES2297465T3/es not_active Expired - Lifetime
- 2004-09-23 DE DE602004010410T patent/DE602004010410T2/de not_active Expired - Fee Related
- 2004-09-23 DK DK04765655T patent/DK1667975T3/da active
-
2006
- 2006-02-20 ZA ZA200601453A patent/ZA200601453B/en unknown
- 2006-03-09 IL IL174213A patent/IL174213A0/en unknown
- 2006-03-27 CO CO06030123A patent/CO5680402A2/es not_active Application Discontinuation
- 2006-04-05 IS IS8399A patent/IS8399A/is unknown
- 2006-04-13 MA MA28933A patent/MA28093A1/fr unknown
- 2006-04-24 NO NO20061791A patent/NO20061791L/no not_active Application Discontinuation
- 2006-11-29 HK HK06113097A patent/HK1094190A1/xx not_active IP Right Cessation
-
2008
- 2008-02-04 HR HR20080055T patent/HRP20080055T3/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| MA28093A1 (fr) | 2006-08-01 |
| PL1667975T3 (pl) | 2008-04-30 |
| IL174213A0 (en) | 2006-08-01 |
| DE602004010410T2 (de) | 2008-10-16 |
| RU2355681C2 (ru) | 2009-05-20 |
| ZA200601453B (en) | 2007-04-25 |
| AU2004283805A1 (en) | 2005-05-06 |
| NO20061791L (no) | 2006-04-24 |
| EP1667975A1 (en) | 2006-06-14 |
| WO2005040124A1 (en) | 2005-05-06 |
| BRPI0414678A (pt) | 2006-11-28 |
| ES2297465T3 (es) | 2008-05-01 |
| RU2006114024A (ru) | 2007-11-10 |
| IS8399A (is) | 2006-04-05 |
| US20070032504A1 (en) | 2007-02-08 |
| HRP20080055T3 (en) | 2008-02-29 |
| CO5680402A2 (es) | 2006-09-29 |
| JP2007506702A (ja) | 2007-03-22 |
| HK1094190A1 (en) | 2007-03-23 |
| DE602004010410D1 (en) | 2008-01-10 |
| EP1667975B1 (en) | 2007-11-28 |
| GB0322629D0 (en) | 2003-10-29 |
| PT1667975E (pt) | 2008-02-29 |
| CA2540022A1 (en) | 2005-05-06 |
| MXPA06003375A (es) | 2006-06-08 |
| CN1856471A (zh) | 2006-11-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SE0302305D0 (sv) | Novel Compounds | |
| IS8108A (is) | Ný efnasambönd | |
| DK1605897T3 (da) | Polyethelen-glycol-link-glp-1-forbindelser | |
| HK1093483A1 (en) | Polymorphic form of n- | |
| IS8228A (is) | Ný asetídínefnasambönd | |
| IS8283A (is) | Umbrotsefni kvetíapíns | |
| IS8089A (is) | Efnasambönd | |
| IL174213A0 (en) | A polymorphic form of 3-phenylsulfonyl-8-piperazin-1-yl-quinoline | |
| IS8292A (is) | Ný efnasambönd | |
| ITMI20042238A1 (it) | Composti per fluoropolirterei | |
| NO20055097D0 (no) | Krystallinske N-formyl-hydroksylaminforbindelser | |
| NO20031736D0 (no) | Forbindelser | |
| SE0303452D0 (sv) | New compounds | |
| NO20054532D0 (no) | Fremgangsmater for a forhindre glukonoylering av proteiner | |
| ITMI20032550A1 (it) | Mescole elastomeriche a base di nerofumo | |
| SE0402103D0 (sv) | Novel compounds | |
| SI1667975T1 (sl) | Polimorfna oblika 3-fenilsulfonil-8-piperazin-1-il-kinolina | |
| SE0302667D0 (sv) | Novel Compounds | |
| SE0300388D0 (sv) | Novel compounds | |
| SE0300118D0 (sv) | Novel Compounds | |
| SE0302369D0 (sv) | New compounds | |
| SE0301120D0 (sv) | New compounds | |
| SE0302368D0 (sv) | New compounds | |
| SE0301246D0 (sv) | New compounds | |
| SE0303078D0 (sv) | New compounds |